LUMO - Lumos Pharma Inc
IEX Last Trade
3.85
-0.060 -1.558%
Share volume: 115,912
Last Updated: Fri 30 Aug 2024 09:56:06 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.91
-0.06
-1.54%
Fundamental analysis
18%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
6%
Performance
5 Days
6.85%
1 Month
116.67%
3 Months
70.31%
6 Months
27.87%
1 Year
41.52%
2 Year
-53.38%
Key data
Stock price
$3.85
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.37 - $4.55
52 WEEK CHANGE
$0.30
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website:
Employees: 36
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 36
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
lumos pharma is an clinical stage biotechnology company focused on developing therapeutics for rare diseases
Recent news